688029 南微医学
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.91314.21510.71911.69410.250
总资产报酬率 ROA (%)3.27211.7288.7869.6418.720
投入资产回报率 ROIC (%)3.76813.70410.46711.5519.742

边际利润分析
销售毛利率 (%)68.31364.50460.95064.18165.758
营业利润率 (%)27.89323.00118.39118.86221.278
息税前利润/营业总收入 (%)27.53220.19815.51420.45423.863
净利润/营业总收入 (%)23.78020.51416.80916.91820.064

收益指标分析
经营活动净收益/利润总额(%)99.35898.62793.49386.16782.073
价值变动净收益/利润总额(%)2.3494.92811.75217.32816.357
营业外收支净额/利润总额(%)0.4311.8131.0092.6926.233

偿债能力分析
流动比率 (X)6.1935.0675.3434.6655.933
速动比率 (X)5.1944.2644.3274.0105.421
资产负债率 (%)13.56716.44815.91017.66214.221
带息债务/全部投入资本 (%)1.2922.1991.1310.318--
股东权益/带息债务 (%)7,489.9764,358.7378,580.46630,894.838-205,378.912
股东权益/负债合计 (%)626.618499.910520.536458.858591.257
利息保障倍数 (X)-57.070-6.258-5.06419.10320.374

营运能力分析
应收账款周转天数 (天)58.88251.67057.92151.7870.000
存货周转天数 (天)237.953228.962223.846157.3470.000